Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.

Karolina DS, Armugam A, Tavintharan S, Wong MT, Lim SC, Sum CF, Jeyaseelan K.

PLoS One. 2011;6(8):e22839. doi: 10.1371/journal.pone.0022839. Epub 2011 Aug 1. Erratum in: PLoS One. 2011;6(9). doi: 10.1371/annotation/698b7123-174f-4a09-95c9-fd6f5017d622.

2.

Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study.

Kong L, Zhu J, Han W, Jiang X, Xu M, Zhao Y, Dong Q, Pang Z, Guan Q, Gao L, Zhao J, Zhao L.

Acta Diabetol. 2011 Mar;48(1):61-9. doi: 10.1007/s00592-010-0226-0. Epub 2010 Sep 21.

PMID:
20857148
3.

Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes.

Herrera BM, Lockstone HE, Taylor JM, Ria M, Barrett A, Collins S, Kaisaki P, Argoud K, Fernandez C, Travers ME, Grew JP, Randall JC, Gloyn AL, Gauguier D, McCarthy MI, Lindgren CM.

Diabetologia. 2010 Jun;53(6):1099-109. doi: 10.1007/s00125-010-1667-2. Epub 2010 Mar 3.

4.

Altered miR-29 Expression in Type 2 Diabetes Influences Glucose and Lipid Metabolism in Skeletal Muscle.

Massart J, Sjögren RJO, Lundell LS, Mudry JM, Franck N, O'Gorman DJ, Egan B, Zierath JR, Krook A.

Diabetes. 2017 Jul;66(7):1807-1818. doi: 10.2337/db17-0141. Epub 2017 Apr 12.

PMID:
28404597
5.

MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of Type 2 Diabetes.

Herrera BM, Lockstone HE, Taylor JM, Wills QF, Kaisaki PJ, Barrett A, Camps C, Fernandez C, Ragoussis J, Gauguier D, McCarthy MI, Lindgren CM.

BMC Med Genomics. 2009 Aug 18;2:54. doi: 10.1186/1755-8794-2-54.

6.

miR-135a targets IRS2 and regulates insulin signaling and glucose uptake in the diabetic gastrocnemius skeletal muscle.

Agarwal P, Srivastava R, Srivastava AK, Ali S, Datta M.

Biochim Biophys Acta. 2013 Aug;1832(8):1294-303. doi: 10.1016/j.bbadis.2013.03.021. Epub 2013 Apr 8.

7.

MicroRNA-194 Modulates Glucose Metabolism and Its Skeletal Muscle Expression Is Reduced in Diabetes.

Latouche C, Natoli A, Reddy-Luthmoodoo M, Heywood SE, Armitage JA, Kingwell BA.

PLoS One. 2016 May 10;11(5):e0155108. doi: 10.1371/journal.pone.0155108. eCollection 2016.

8.

Dysregulated miR-103 and miR-143 expression in peripheral blood mononuclear cells from induced prediabetes and type 2 diabetes rats.

Vatandoost N, Amini M, Iraj B, Momenzadeh S, Salehi R.

Gene. 2015 Nov 1;572(1):95-100. doi: 10.1016/j.gene.2015.07.015. Epub 2015 Jul 8.

PMID:
26164754
9.

Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization.

Ortega FJ, Mercader JM, Moreno-Navarrete JM, Rovira O, Guerra E, Esteve E, Xifra G, Martínez C, Ricart W, Rieusset J, Rome S, Karczewska-Kupczewska M, Straczkowski M, Fernández-Real JM.

Diabetes Care. 2014;37(5):1375-83. doi: 10.2337/dc13-1847. Epub 2014 Jan 29.

PMID:
24478399
10.

Activin A impairs insulin action in cardiomyocytes via up-regulation of miR-143.

Blumensatt M, Greulich S, Herzfeld de Wiza D, Mueller H, Maxhera B, Rabelink MJ, Hoeben RC, Akhyari P, Al-Hasani H, Ruige JB, Ouwens DM.

Cardiovasc Res. 2013 Nov 1;100(2):201-10. doi: 10.1093/cvr/cvt173. Epub 2013 Jun 28.

PMID:
23812417
11.

Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat.

Esguerra JL, Bolmeson C, Cilio CM, Eliasson L.

PLoS One. 2011 Apr 7;6(4):e18613. doi: 10.1371/journal.pone.0018613.

12.

Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes.

He A, Zhu L, Gupta N, Chang Y, Fang F.

Mol Endocrinol. 2007 Nov;21(11):2785-94. Epub 2007 Jul 24.

PMID:
17652184
13.

Glucose tolerance is associated with differential expression of microRNAs in skeletal muscle: results from studies of twins with and without type 2 diabetes.

Bork-Jensen J, Scheele C, Christophersen DV, Nilsson E, Friedrichsen M, Fernandez-Twinn DS, Grunnet LG, Litman T, Holmstrøm K, Vind B, Højlund K, Beck-Nielsen H, Wojtaszewski J, Ozanne SE, Pedersen BK, Poulsen P, Vaag A.

Diabetologia. 2015 Feb;58(2):363-73. doi: 10.1007/s00125-014-3434-2. Epub 2014 Nov 19.

14.

MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats.

Wang XH, Qian RZ, Zhang W, Chen SF, Jin HM, Hu RM.

Clin Exp Pharmacol Physiol. 2009 Feb;36(2):181-8. doi: 10.1111/j.1440-1681.2008.05057.x. Epub 2008 Sep 26.

PMID:
18986336
15.

Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies.

Zhu H, Leung SW.

Diabetologia. 2015 May;58(5):900-11. doi: 10.1007/s00125-015-3510-2. Epub 2015 Feb 13.

PMID:
25677225
16.

Influence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetes.

Chakraborty C, Doss CG, Bandyopadhyay S, Agoramoorthy G.

Wiley Interdiscip Rev RNA. 2014 Sep-Oct;5(5):697-712. doi: 10.1002/wrna.1240. Epub 2014 Jun 18. Review.

PMID:
24944010
17.

Comparison of Transcriptome Between Type 2 Diabetes Mellitus and Impaired Fasting Glucose.

Cui Y, Chen W, Chi J, Wang L.

Med Sci Monit. 2016 Dec 1;22:4699-4706.

18.

microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.

Brunet Vega A, Pericay C, Moya I, Ferrer A, Dotor E, Pisa A, Casalots À, Serra-Aracil X, Oliva JC, Ruiz A, Saigí E.

Oncol Rep. 2013 Jul;30(1):320-6. doi: 10.3892/or.2013.2475. Epub 2013 May 15.

PMID:
23673725
19.

Regulation of Insulin Resistance by Multiple MiRNAs via Targeting the GLUT4 Signalling Pathway.

Zhou T, Meng X, Che H, Shen N, Xiao D, Song X, Liang M, Fu X, Ju J, Li Y, Xu C, Zhang Y, Wang L.

Cell Physiol Biochem. 2016;38(5):2063-78. doi: 10.1159/000445565. Epub 2016 May 11.

20.

Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients.

Collares CV, Evangelista AF, Xavier DJ, Rassi DM, Arns T, Foss-Freitas MC, Foss MC, Puthier D, Sakamoto-Hojo ET, Passos GA, Donadi EA.

BMC Res Notes. 2013 Nov 26;6:491. doi: 10.1186/1756-0500-6-491.

Supplemental Content

Support Center